Researchers still use Nottingham grade and tumor stage as prognostic factors, which are classic parameters; clinical datasets and molecular biology biomarkers such as estrogen receptors, progesterone receptors, and human epidermal growth factor 2 are recognized as useful tools in breast cancer progosis [11,12]. Here, PGR is linked to neoplasm.